Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
Mujahid A. Rizvi(Northwestern University), Steven T. Rosen(City of Hope)
Cited by 81
Related Papers
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
|Journal of Hematology & Oncology|2021|66
SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|55
Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine
|Journal of Biological Chemistry|2009|44
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide
|Cancer Gene Therapy|2022|20